drugset / Trial / NCT01302015

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease

NCT01302015 ↗

Completed 15 enrolled R-Bio
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Buerger's disease.

Timeline

Start
2007-12
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject RNL-Vascostem® Cell therapy 5e+06 cells/kg Intramuscular